| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2017 |
Kraus RJ, Yu X, Cordes BA, Sathiamoorthi S, Iempridee T, Nawandar DM, Ma S, Romero-Masters JC, McChesney KG, Lin Z, Makielski KR, Lee DL, Lambert PF, Johannsen EC, Kenney SC, et al. Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. Plos Pathogens. 13: e1006404. PMID 28617871 DOI: 10.1371/Journal.Ppat.1006404 |
0.295 |
|
| 2011 |
Hegde S, Lockridge JL, Becker YA, Ma S, Kenney SC, Gumperz JE. Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands. Journal of Autoimmunity. 37: 28-38. PMID 21486688 DOI: 10.1016/j.jaut.2011.03.001 |
0.292 |
|
| 2015 |
Nawandar DM, Wang A, Makielski K, Lee D, Ma S, Barlow E, Reusch J, Jiang R, Wille CK, Greenspan D, Greenspan JS, Mertz JE, Hutt-Fletcher L, Johannsen EC, Lambert PF, et al. Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells. Plos Pathogens. 11: e1005195. PMID 26431332 DOI: 10.1371/Journal.Ppat.1005195 |
0.261 |
|
| 2017 |
Zumwalde NA, Sharma A, Xu X, Ma S, Schneider CL, Romero-Masters JC, Hudson AW, Gendron-Fitzpatrick A, Kenney SC, Gumperz JE. Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model. Jci Insight. 2. PMID 28679955 DOI: 10.1172/jci.insight.93179 |
0.26 |
|
| 2020 |
Romero-Masters JC, Ohashi M, Djavadian R, Eichelberg MR, Hayes M, Zumwalde NA, Bristol JA, Nelson SE, Ma S, Ranheim EA, Gumperz JE, Johannsen EC, Kenney SC. An EBNA3A-mutated Epstein-Barr virus (EBV) retains the capacity for lymphomagenesis in a cord blood-humanized mouse model. Journal of Virology. PMID 32132242 DOI: 10.1128/JVI.02168-19 |
0.254 |
|
| 2015 |
Ma SD, Xu X, Plowshay J, Ranheim EA, Burlingham WJ, Jensen JL, Asimakopoulos F, Tang W, Gulley ML, Cesarman E, Gumperz JE, Kenney SC. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis. The Journal of Clinical Investigation. 125: 304-15. PMID 25485679 DOI: 10.1172/Jci76357 |
0.247 |
|
| 2018 |
Romero-Masters JC, Ohashi M, Djavadian R, Eichelberg MR, Hayes M, Bristol JA, Ma S, Ranheim EA, Gumperz J, Johannsen EC, Kenney SC. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. Plos Pathogens. 14: e1007221. PMID 30125329 DOI: 10.1371/journal.ppat.1007221 |
0.237 |
|
| 2016 |
Ma SD, Xu X, Jones R, Delecluse HJ, Zumwalde NA, Sharma A, Gumperz JE, Kenney SC. PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model. Plos Pathogens. 12: e1005642. PMID 27186886 DOI: 10.1371/journal.ppat.1005642 |
0.231 |
|
| 2016 |
Golden S, Yu XM, Odorico S, Jain V, Marin A, Ma S, Kenney S, Chen H. The Epstein-Barr virus EBNA2 protein induces a subset of NOTCH target genes in thyroid cancer cell lines but fails to suppress proliferation. Surgery. PMID 27847111 DOI: 10.1016/j.surg.2016.06.068 |
0.212 |
|
| 2012 |
Ma SD, Yu X, Mertz JE, Gumperz JE, Reinheim E, Zhou Y, Tang W, Burlingham WJ, Gulley ML, Kenney SC. An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. Journal of Virology. 86: 7976-87. PMID 22623780 DOI: 10.1128/Jvi.00770-12 |
0.202 |
|
| 2017 |
Ma SD, Tsai MH, Romero-Masters JC, Ranheim EA, Huebner SM, Bristol J, Delecluse HJ, Kenney SC. LMP1 and LMP2A collaborate to promote Epstein-Barr virus (EBV)-induced B cell lymphomas in a cord blood-humanized mouse model but are not essential. Journal of Virology. PMID 28077657 DOI: 10.1128/JVI.01928-16 |
0.197 |
|
| 2015 |
Wille CK, Nawandar DM, Henning AN, Ma S, Oetting KM, Lee D, Lambert P, Johannsen EC, Kenney SC. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch. Proceedings of the National Academy of Sciences of the United States of America. PMID 26663912 DOI: 10.1073/Pnas.1513432112 |
0.189 |
|
| 2013 |
Lockridge JL, Zhou Y, Becker YA, Ma S, Kenney SC, Hematti P, Capitini CM, Burlingham WJ, Gendron-Fitzpatrick A, Gumperz JE. Mice engrafted with human fetal thymic tissue and hematopoietic stem cells develop pathology resembling chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 1310-22. PMID 23806772 DOI: 10.1016/J.Bbmt.2013.06.007 |
0.177 |
|
| 2017 |
Bilger A, Plowshay J, Ma S, Nawandar D, Barlow EA, Romero-Masters JC, Bristol JA, Li Z, Tsai MH, Delecluse HJ, Kenney SC. Leflunomide/teriflunomide inhibit Epstein-barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication. Oncotarget. PMID 28574826 DOI: 10.18632/Oncotarget.17863 |
0.163 |
|
| 2011 |
Ma SD, Hegde S, Young KH, Sullivan R, Rajesh D, Zhou Y, Jankowska-Gan E, Burlingham WJ, Sun X, Gulley ML, Tang W, Gumperz JE, Kenney SC. A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. Journal of Virology. 85: 165-77. PMID 20980506 DOI: 10.1128/Jvi.01512-10 |
0.118 |
|
| 2010 |
Ma SD, Lancto CA, Enomoto S, Abrahamsen MS, Rutherford MS. Expression and regulation of IL-22 by bovine peripheral blood gamma/delta T cells. Gene. 451: 6-14. PMID 19879340 DOI: 10.1016/J.Gene.2009.08.018 |
0.071 |
|
| Hide low-probability matches. |